↓ Skip to main content

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-mo…

Overview of attention for article published in Lancet Neurology, April 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news
1 news outlet
wikipedia
1 Wikipedia page

Citations

dimensions_citation
191 Dimensions

Readers on

mendeley
220 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Published in
Lancet Neurology, April 2011
DOI 10.1016/s1474-4422(11)70073-4
Pubmed ID
Authors

Olivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, Joseph Jankovic, Anthony Lang, J William Langston, Eldad Melamed, Werner Poewe, Fabrizio Stocchi, Eduardo Tolosa, Eli Eyal, Yoni M Weiss, C Warren Olanow

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 <1%
United States 2 <1%
Chile 1 <1%
Ireland 1 <1%
India 1 <1%
Colombia 1 <1%
Canada 1 <1%
Czechia 1 <1%
Unknown 210 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 16%
Student > Bachelor 30 14%
Student > Master 24 11%
Other 21 10%
Student > Ph. D. Student 18 8%
Other 47 21%
Unknown 45 20%
Readers by discipline Count As %
Medicine and Dentistry 75 34%
Neuroscience 23 10%
Agricultural and Biological Sciences 17 8%
Psychology 15 7%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Other 24 11%
Unknown 57 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2015.
All research outputs
#3,415,350
of 25,374,647 outputs
Outputs from Lancet Neurology
#1,772
of 4,011 outputs
Outputs of similar age
#15,308
of 120,387 outputs
Outputs of similar age from Lancet Neurology
#9
of 28 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,011 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,387 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.